Citation: | MA Jingjie, CHEN Yimeng, JIANG Qixin, YANG Jie, WEN Xiaodong. Effects of ethanol extract of Si Miao Wan on hepatic lipid accumulation[J]. Journal of China Pharmaceutical University, 2021, 52(6): 725-734. DOI: 10.11665/j.issn.1000-5048.20210611 |
[1] |
. Nat Rev Endocrinol,2019,15(5):288-298.
|
[2] |
Zheng Y,Ley SH,Hu FB.Global aetiology and epidemiology of type 2 diabetes mellitus and its complications[J].Nat Rev Endocrinol,2018,14(2):88-98.
|
[3] |
Sanyal AJ.Past,present and future perspectives in nonalcoholic fatty liver disease[J]. Nat Rev Gastroenterol Hepatol,2019,16(6):377-386.
|
[4] |
Ota T.Molecular mechanisms of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)[J]. Adv Exp Med Biol,2021,1261:223-229.
|
[5] |
Cetin EG,Demir N,Sen I.The relationship between insulin resistance and liver damage in non-alcoholic fatty liver patients[J]. Sisli Etfal Hastan Tip Bul,2020,54(4):411-415.
|
[6] |
Wang CR,Xiang N. Discussion on the relation dysfunction of between liver,spleen and kidney and metabolic syndrome[J].World Chin Med(世界中医药),2013,8(12):1412-1413.
|
[7] |
Endocrinology and metabolism committee of integrated traditional chinese and western medicine physicians branch of chinesemedical doctor association. guidelines for the diagnosis and treatment of diabetes mellitus with hyperlipidemia[J]. World Chin Med (世界中医药),2021,16(16):2377-2385.
|
[8] |
Hu H,Li LT,Liu YW,et al.Effect of modified simiaosan on inflammatory factors and neuropeptide substances ofpatients with synovitis of knee joint and damp-heat obstruction collateral syndrome[J].Chin J Exp Tradit Med Form(中国实验方剂学杂志),2020,26(6):97-102.
|
[9] |
Zhao XB,Zhao YK,Li LY. Clinical study on the treatment of acute gouty arthritis by Simiao pills[J]. J New Chin Med(新中医),2021,53(4):58-60.
|
[10] |
Chang WG,Li K,Guan FY,et al.Berberine pretreatment confers cardioprotection against ischemia-reperfusion injury in a rat model of type 2 diabetes[J]. J Cardiovasc Pharmacol Ther,2016,21(5):486-494.
|
[11] |
Cai ZY,Wang CL,Lu TT,et al.Berberine alleviates amyloid-beta pathogenesis via activating LKB1/AMPK signaling in the brain of APP/PS1 transgenic mice[J]. Curr Mol Med,2019,19(5):342-348.
|